Recent advances in molecular farming using monocot plants
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15640%2F22%3A73618621" target="_blank" >RIV/61989592:15640/22:73618621 - isvavai.cz</a>
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S073497502200009X?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S073497502200009X?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.biotechadv.2022.107913" target="_blank" >10.1016/j.biotechadv.2022.107913</a>
Alternative languages
Result language
angličtina
Original language name
Recent advances in molecular farming using monocot plants
Original language description
Heterologous synthesis of proteins or peptides in plant-based systems, referred to as plant molecular farming, is a practical and safe approach for the large-scale and cost-effective production of therapeutic biomolecules. In this context, monocotyledonous plants, and especially cereals, have been considered attractive vehicles for producing high-value recombinant proteins. The endosperm, as the largest grain storage compartment, offers an appropriate environment for long-lasting protein accumulation. During the last decades, fascinating progress has been achieved in the gene transfer technology and genetic manipulation of the monocot crops using either Agrobacterium tumefaciens or direct gene transfer by biolistic methods. Our group has recently expressed biologically active recombinant human peptide cathelicidin in barley grains using endosperm-specific promoter and brought such engineered lines to field cultivation under current EU regulations for genetically modified organisms. This article reviews the most recent advances and strategies for the production of biopharmaceutical proteins in transgenic monocots, highlighting various aspects involved in recombinant protein accumulation in grains, and discussing current bottlenecks and perspectives for the biosynthesis of therapeutic molecules using different monocot plant platforms.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10620 - Other biological topics
Result continuities
Project
<a href="/en/project/EF17_048%2F0007323" target="_blank" >EF17_048/0007323: Development of pre-applied research in nanotechnogy and biotechnology</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
BIOTECHNOLOGY ADVANCES
ISSN
0734-9750
e-ISSN
1873-1899
Volume of the periodical
58
Issue of the periodical within the volume
September
Country of publishing house
GB - UNITED KINGDOM
Number of pages
14
Pages from-to
"nečíslováno"
UT code for WoS article
000830105100006
EID of the result in the Scopus database
2-s2.0-85123676608